Cabliz 0.25mg Tablet (Cabergoline 0.25mg)

Cabliz 0.25mg Tablet

Cabliz 0.25 mg Tablet is used to treat excess production of a natural hormone called prolactin. Excess production of this hormone is due to unknown causes or abnormal growths in the pituitary. This medicine helps in preventing infertility, sexual problems, and bone loss caused by excess prolactin production in men and in women who are not breastfeeding. It is also used as a second line therapy in the treatment of signs and symptoms of Parkinson’s disease along with carbidopa-levodopa or as a single agent in case of failure of or intolerance to a non-ergot compound.

Substitutes

List of substitutes for Cabliz 0.25 mg Tablet
Caberlin 0.25 mg Tablet
Sun Pharma Laboratories Ltd.
Cabgolin 0.25 mg Tablet
Sun Pharma Laboratories Ltd.
Cabgon 0.25 mg Tablet
Intas Pharmaceuticals Ltd.
CB-LIN 0.25 mg Tablet
Serum Institute Of India Ltd.
Colette 0.25 mg Tablet
Cipla Ltd.

Side effects

Major & minor side effects for Cabliz 0.25 mg Tablet
Hypersensitivity
Painful menstruation
Burning or tingling sensation of hands and feet
Breast pain
Heartburn
Constipation
Nausea and vomiting
Blurred vision
Difficulty in breathing
Decrease in frequency of urination
Swelling of ankles or feet
Uses of Cabliz 0.25 mg Tablet
What is it prescribed for?
Hyperprolactinemia
Cabliz 0.25 mg Tablet is used in the treatment of hyperprolactinemia, a condition where there is an excess production of prolactin which may cause infertility, sexual problems, or bone loss in men and women who are not breastfeeding.
Parkinson’s disease
Cabliz 0.25 mg Tablet is used as a second line therapy in the treatment of signs and symptoms of Parkinson’s disease as an adjunct to carbidopa-levodopa or as a single agent in case of failure of or intolerance to a non-ergot compound.

Related Product

Cabliz 0.25 mg Tablet
Cabliz 0.5 mg Tablet

When not to use?

Allergy
This medicine is not recommended for use in patients with a known allergy to cabergoline or any ergot alkaloids or any other components present along with it.
Hypertension
This medicine is not recommended for use in patients with uncontrolled hypertension due to the increased risk of serious cardiovascular adverse effects.

Warnings

Warnings for special population
Pregnancy
This medicine is considered safe for consumption by pregnant women. However, all the risks and benefits should be discussed with the doctor before taking this medicine.
Breast-feeding
This medicine is not recommended for use in breastfeeding women.
General warnings
Hepatic dysfunction
Caution is advised while using this medicine in patients with liver diseases due to an increased risk of severe adverse effects. Close monitoring of liver functions is advised for such patients.
Use in pediatrics
This medicine is not recommended for use in children.
Lactation suppression
This medicine is not recommended for suppressing milk production due to the increased risk of serious adverse effects such as stroke, hypertension, and seizures.

Dosage

Missed Dose
Take the missed dose as soon as you remember it. If it is almost time for your next dose, skip the missed dose. Do not double your dose to make up for the missed dose.
Overdose
Seek emergency medical treatment or contact the doctor immediately in case of an overdose.

Interactions
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol
Description
N/A
Instructions
Alcohol should not be consumed while receiving this medicine since it may increase the risk of dizziness, drowsiness, and difficulty concentrating. It is advised that you do not perform any activities that require high mental alertness like driving a vehicle or operating heavy machinery if alcohol is consumed during treatment with this medicine.
Interaction with Medicine
Clarithromycin
Erythromycin
Sodium oxybate
Lorcaserin
Disease interactions
Cardiac valvular disorders
Use of Cabliz 0.25 mg Tablet in patients with heart valve disorders is not recommended. It is advised to perform a cardiovascular evaluation prior to beginning therapy with this medicine. It is advised that you should inform the doctor about all your medical conditions before beginning treatment with this medicine.
Hypotension
Caution is advised while using this medicine in patients with Parkinson’s disease and patients who are receiving high blood pressure medicines due to the increased risk of hypotension while getting up from a lying or sitting position. Close monitoring of blood pressure is necessary during treatment with this medicine. Patients are advised to get up slowly from a sitting or lying position to avoid these episodes.
Psychosis
Caution is advised while using this medicine in patients with a history of psychotic episodes due to the increased risk of worsening of the patient’s condition. Patients should be monitored closely for any changes in mood or behavior.
Food interactions
Information not available.
Lab interactions
Information not available.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.

General Instructions

Take Cabliz 0.25 mg Tablet following all the instructions on the leaflet or the package insert. Do not take in larger amounts than advised/prescribed. Consult the doctor if you experience any undesirable effects. Ensure that the treatment course is completed. Do not stop the use of this medicine without consulting your doctor.